Tissue Engineering Market Size, Share, Growth Analysis, By Product(Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds), By Material(Synthetic Materials, Biologically Derived Materials), By Application(Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases), By End User(Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2236 | Region: Global | Published Date: October, 2024
Pages: 219 |Tables: 66 |Figures: 75

Tissue Engineering Market Insights

Global Tissue Engineering Market size was valued at USD 3.75 billion in 2022 and is poised to grow from USD 4.42 billion in 2023 to USD 13.74 billion by 2031, growing at a CAGR of 15.23% during the forecast period (2024-2031).

The expansion of understanding about biomaterials coupled with technological developments and the increased requirements for regenerative medicine results in significant developments and improvements in the global tissue engineering industry. These attributes have undoubtedly enhanced the quality of healthcare by providing alternatives for tissue repair and restoration. One of the key trends witnessed in the global tissue engineering market is the increasing use of regenerative medicine applications. If the aim is to restore or reconstruct damaged tissues and organs using living constructs, then it is no wonder that tissue engineering is a major component of those therapies that seek regeneration. The advent of the organ-on-a-chip era is a great development. These tiny devices mimic human organ characteristics and tissue reactions in a safe and regulated setting. 

Scientific applications of tissue engineering are emerging from research labs. Commercialization of tissue-engineered products and increased acceptance of scientific translation indicate a move towards practical healing solutions for victims. Collaborations between biotechnology businesses, healthcare organizations, and research institutions are becoming more common. These collaborations aim to increase the development and commercialization of tissue-engineered products by combining knowledge, resources, and generation. Within the global tissue engineering market, regulatory advancements are crucial. A smoother and more reliable route to market access is being promoted by the FDA's attempts to provide clear guidelines and frameworks for the approval of tissue-engineered products. As a specialized field, dental tissue engineering is becoming more popular. 

Market snapshot - 2024-2031

Global Market Size

USD 13 Billion

Largest Segment

Synthetic Material

Fastest Growth

Synthetic Material

Growth Rate

10.7% CAGR

Global Surgical Lights Market ($ Bn)
Country Share by North America (%)

To get more reports on the above market click here to Buy The Report

Tissue Engineering Market Segmental Analysis

Global Tissue Engineering Market is segmented by Product, Material, Application, End User, and Region. Based on Product, the market is segmented into Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds, Other Biological Material-Based Scaffolds)), Tissue Grafts (Allografts, Autografts, Synthetic Grafts, Xenografts), Other Products. Based on Material, the market is segmented into Synthetic Materials, Biologically Derived Materials. Based on Application, the market is segmented into Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases, Other Applications. Based on End User, the market is segmented into Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. 

Analysis by Type 

As per categorization by type, the market is classified as synthetic scaffold material, biologically derived scaffold material, and others. Among these, biologically derived scaffold material earned the largest share and continues to hold the dominant global tissue engineering market share. Scaffolds for tissue engineering that are made of materials that come from biological sources are witnessing a rapid share of the global tissue engineering owing to their natural affinity to human body tissues, thus favoring the growth and differentiation of cells. The new developments concentrate on the improvement of the tensile characteristics of these materials and their biodegradation and cell adhesion. Their strengths arise from the fact these materials are very good imitations of the extracellular matrix, hence enhancing tissue repair processes. In this context, such elements made from collagen, fibrin or after decellularized tissues, play an invaluable role in reinforcing the growth of various functional substitutes and tissue regeneration methods. 

Synthetic scaffold materials are poised to be the fastest-growing segment in the global tissue engineering market due to their customizable properties, scalability, and cost-effectiveness. In contrast with the materials obtained from nature, synthetic scaffolds can be designed to conform to precise mechanical, structural and degradation parameters, making them flexible for many uses. Advancements in biopolymers and 3D printing methods are raising their capabilities by enhancing the cell attachment and tissue generation activities. The rising need for individualized therapies, in line with the development of synthetic biomaterials, is encouraging the use of such materials hence they are becoming an essential component of healthy restoration and tissue engineering. 

Analysis by Application 

Orthopedics and musculoskeletal applications are leading the global tissue engineering market due to the increasing prevalence of bone and joint disorders, along with advancements in regenerative medicine. The advancements prioritize the creation of scaffolds, biomaterials, as well as stem cell therapies for the purposes of repairing or regenerating cartilage, bone, and soft tissues. These technologies avails possibilities for conditions resulting due to osteoarthritis, fractures, tendon injuries, which fasten the recovery process and improve the efficacy of the treated body parts. This segment has been dominating the share due to increases in musculoskeletal injuries along with the need for effective treatments causing an increase in demand for more personalized orthopedic products and less invasive procedures. 

The Skin & Integumentary segment is set to become the fastest growing in the global tissue engineering market due to the rising incidence of skin injuries, burns, and chronic wounds, alongside advancements in regenerative medicine. The focus of innovations is on the creation of bioengineered skin substitutes such as scaffolds and cellular therapies which expedite healing and functionality of the wound. The Skin & Integumentary segment is forecasting rapid growth, due to the booming treatments in burn care, diabetic ulcers and surgical wound management. In addition, the demand for better molds to fit the patient’s deformity in skin and cosmetic surgeries and the rehabilitation therapies of the patients have enhanced it too. 

Global Surgical Lights Market By Type (%)

To get detailed analysis on other segments, Request For Free Sample Report

Tissue Engineering Market Regional Insights

North America dominates the global tissue engineering market due to its advanced healthcare infrastructure, significant investment in research and development, and strong presence of leading biotechnology and pharmaceutical companies. Strong investment in regenerative medicine is available in the region, due to both public programmes and private partnerships. It is also contributed by the current market needs and demands for more advanced treatment in orthopedics, skin and musculoskeletal tissues, among others. Furthermore, in North America, where there is a growing elderly population and an increasing number of chronic conditions, there is also a growing demand for efficacious methods of tissue engineering. Consequently, the region is also the first to embrace advances in tissue engineering owing to the presence of established policies as well as appropriate health care systems. 

Asia Pacific is the fastest-growing region in the global tissue engineering market, driven by rapid advancements in healthcare infrastructure, increased medical research investments, and a rising demand for regenerative therapies. The progressive deterioration of the region’s aging population, and the increased occurrence of chronic diseases such as diabetes and osteoarthritis are fast tracking demand for tissue engineering products. Furthermore, the governments in countries such as China, Japan, and India view healthcare innovation as a priority region and therefore, have formulated workable policies and cash for sponsoring tissue engineering studies. More so, the region’s developing medical apparatus and biotechnological industries combined with decreased costs of production are also contributing to the increase in market growth in Asia Pacific. 

Global Surgical Lights Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Tissue Engineering Market Dynamics

Tissue Engineering Market Drivers 

Rising Incidence of Chronic Diseases 

  • The increasing prevalence of chronic diseases such as diabetes, osteoarthritis, and cardiovascular conditions is significantly driving the global tissue engineering market. Due to the fact that such conditions often result in damage to tissues and organs, there is an increase in the need for advanced regenerative therapies that will aid in repairing or replacing the damaged tissues which is in turn increasing the global tissue engineering market size. 

Advancements in Regenerative Medicine 

  • The global tissue engineering market is positively impacted the most by the innovation of technologies that are used in regenerative medicine including but not limited to stem cell therapy, tissue engineering biomaterials and 3D bioprinting. These innovations facilitate improved and customized rehabilitative treatment of tissue repair and reconstruction process, thereby improving the healing processes and widening the use in different branches of medicine. 

Tissue Engineering Market Restraints 

Ethical and Safety Concerns 

  • Ethical concerns surrounding the use of stem cells and other biologically derived materials in tissue engineering continue to hinder market progress. The concerns associated with obtaining, altering and the use of these substances for a prolonged period of time, raise the eyebrows of both regulating bodies and end users, which in turn hinders the use and development of new treatment modalities. 

Limited Clinical Evidence and Long-Term Efficacy 

  • The lack of sufficient clinical evidence and long-term data on the effectiveness and safety of tissue-engineered products restricts their wide-scale use. Many treatments are still in early-stage trials qualitatively, and as there are no proven long-term results, these providers are indifferent in implementing these therapies, therefore restricting the global tissue engineering market growth and investment levels.

Request Free Customization of this report to help us to meet your business objectives.

Tissue Engineering Market Competitive Landscape

Global tissue engineering market is very competitive in nature and many of the companies are focusing on giving out solutions which are primarily regenerative in nature. Medtronic, Stryker Corporation, Zimmer Biomet, and Johnson & Johnson are all major competitors in the performance of quality biodegradable implants and regenerative medic. These companies also devote great proportions of their income to Research and Development and Consumer, and Corporate acquisitions to further expand the scope of their product offer. Also, the growing number of small biotech companies further adds to the competitive environment as they also encourage innovation especially in areas of stem cell treatments and personalization of tissue regeneration. 

Top Player’s Company Profiles in Global Tissue Engineering Market

  • Organogenesis Inc. 
  • Integra LifeSciences 
  • AbbVie Inc. 
  • MiMedx Group, Inc. 
  • Johnson & Johnson Services, Inc. 
  • Smith & Nephew PLC 
  • Baxter 
  • BD 
  • B. Braun SE 
  • Teijin Limited 
  • Institut Straumann AG 
  • Medtronic 
  • NuVasive, Inc. 
  • Stryker 
  • Terumo Corporation 
  • W. L. Gore & Associates, Inc. 
  • Zimmer Biomet 
  • TissueTech 
  • Collplant Biotechnologies Ltd. 
  • Sumitomo Pharma Co., Ltd. 
  • Matricel GmbH 
  • Mallinckrodt 
  • Regrow Biosciences Pvt. Ltd. 
  • Vericel Corporation 
  • Tecnoss S.R.L. 
  • Tegoscience 
  • Tissue Regenix

Global Tissue Engineering Market Recent Developments

  • In August 2024, Organogenesis has now advanced a new class of wound healing product, which involves the use of sophisticated tissue-engineered skin, that has already received an FDA approval for marketing. The new product enhances acceleration of soft tissue healing, especially for chronic diabetic wounds by promoting enhanced tissue regeneration. The approval is of great importance in the company’s quest for growing its regenerative medicine portfolio. 
  • In September 2024, Stryker Corporation unveiled a new tissue engineering product aimed at improving cartilage repair in joint surgeries. The product leverages a combination of bioactive scaffolds and stem cell technology to promote tissue regeneration and reduce recovery times. Stryker’s approach offers promising advancements in orthopedic tissue engineering. 
  • In October 2024, Medtronic recently announced the launch of a next-generation bone graft substitute, designed to enhance tissue regeneration in orthopedic surgeries. The new product utilizes advanced biomaterials to support faster healing and greater patient outcomes. The objective of this innovation is to enhance the management strategies for treating bone defects and spinal injuries.

Tissue Engineering Key Market Trends

  • Increased Adoption of 3D Bioprinting in Tissue Engineering: Revolutionizing tissue engineering, 3D bioprinting makes it possible to anatomize and construct complex tissue structures with precision. There is an upward rise in this trend appreciate due to improvements in printing technologies and biomaterials that allow for more idiosyncratic and functional tissues constructs which facilitates regenerative medicine further and shortens its products development cycle. 
  • Growing Investment in Stem Cell-Based Therapies: Stem cell-based therapies are rapidly advancing in the global tissue engineering market, driven by their potential for regenerative healing. Investment in stem cell research is increasing, with companies and research institutions focusing on harnessing stem cells for tissue regeneration, particularly in musculoskeletal, skin, and cartilage applications. 

Tissue Engineering Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. 

As per SkyQuest analysis, the global tissue engineering market is rapidly advancing due to technological innovations, such as 3D bioprinting and stem cell-based therapies, as well as a growing demand for regenerative medicine. As various sectors like orthopedics and skin care expand, collaborations and investments in research and development continue to drive progress. 

The progress in regulation in conjunction with tissue engineered products coming into the market is offering realistic healing solutions. North America is still at the forefront of this industry, but the Asia Pacific region is fast becoming one due to innovations in healthcare, an increasing elderly population and favourable government policies that encourage the growth of the market. 

Report Metric Details
Market size value in 2022 USD 3.75 billion
Market size value in 2031 USD 13.74 billion
Growth Rate 15.23%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds, Other Biological Material-Based Scaffolds)), Tissue Grafts (Allografts, Autografts, Synthetic Grafts, Xenografts), Other Products
  • Material
    • Synthetic Materials, Biologically Derived Materials
  • Application
    • Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases, Other Applications
  • End User
    • Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Organogenesis Inc. 
  • Integra LifeSciences 
  • AbbVie Inc. 
  • MiMedx Group, Inc. 
  • Johnson & Johnson Services, Inc. 
  • Smith & Nephew PLC 
  • Baxter 
  • BD 
  • B. Braun SE 
  • Teijin Limited 
  • Institut Straumann AG 
  • Medtronic 
  • NuVasive, Inc. 
  • Stryker 
  • Terumo Corporation 
  • W. L. Gore & Associates, Inc. 
  • Zimmer Biomet 
  • TissueTech 
  • Collplant Biotechnologies Ltd. 
  • Sumitomo Pharma Co., Ltd. 
  • Matricel GmbH 
  • Mallinckrodt 
  • Regrow Biosciences Pvt. Ltd. 
  • Vericel Corporation 
  • Tecnoss S.R.L. 
  • Tegoscience 
  • Tissue Regenix
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Tissue Engineering Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Tissue Engineering Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Tissue Engineering Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Tissue Engineering Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Tissue Engineering Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Tissue Engineering Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Tissue Engineering Market size was valued at USD 3.75 billion in 2022 and is poised to grow from USD 4.42 billion in 2023 to USD 13.74 billion by 2031, growing at a CAGR of 15.23% during the forecast period (2024-2031).

Global tissue engineering market is very competitive in nature and many of the companies are focusing on giving out solutions which are primarily regenerative in nature. Medtronic, Stryker Corporation, Zimmer Biomet, and Johnson & Johnson are all major competitors in the performance of quality biodegradable implants and regenerative medic. These companies also devote great proportions of their income to Research and Development and Consumer, and Corporate acquisitions to further expand the scope of their product offer. Also, the growing number of small biotech companies further adds to the competitive environment as they also encourage innovation especially in areas of stem cell treatments and personalization of tissue regeneration.  'Organogenesis Inc. ', 'Integra LifeSciences ', 'AbbVie Inc. ', 'MiMedx Group, Inc. ', 'Johnson & Johnson Services, Inc. ', 'Smith & Nephew PLC ', 'Baxter ', 'BD ', 'B. Braun SE ', 'Teijin Limited ', 'Institut Straumann AG ', 'Medtronic ', 'NuVasive, Inc. ', 'Stryker ', 'Terumo Corporation ', 'W. L. Gore & Associates, Inc. ', 'Zimmer Biomet ', 'TissueTech ', 'Collplant Biotechnologies Ltd. ', 'Sumitomo Pharma Co., Ltd. ', 'Matricel GmbH ', 'Mallinckrodt ', 'Regrow Biosciences Pvt. Ltd. ', 'Vericel Corporation ', 'Tecnoss S.R.L. ', 'Tegoscience ', 'Tissue Regenix'

Increased Adoption of 3D Bioprinting in Tissue Engineering: Revolutionizing tissue engineering, 3D bioprinting makes it possible to anatomize and construct complex tissue structures with precision. There is an upward rise in this trend appreciate due to improvements in printing technologies and biomaterials that allow for more idiosyncratic and functional tissues constructs which facilitates regenerative medicine further and shortens its products development cycle. 

North America dominates the global tissue engineering market due to its advanced healthcare infrastructure, significant investment in research and development, and strong presence of leading biotechnology and pharmaceutical companies. Strong investment in regenerative medicine is available in the region, due to both public programmes and private partnerships. It is also contributed by the current market needs and demands for more advanced treatment in orthopedics, skin and musculoskeletal tissues, among others. Furthermore, in North America, where there is a growing elderly population and an increasing number of chronic conditions, there is also a growing demand for efficacious methods of tissue engineering. Consequently, the region is also the first to embrace advances in tissue engineering owing to the presence of established policies as well as appropriate health care systems. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Tissue Engineering Market

Report ID: SQMIG35H2236

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE